Bradykinin Receptor Antagonists

Name
Bradykinin Receptor Antagonists
Accession Number
DBCAT001656
Description

Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.

Drugs
DrugDrug Description
AnatibantInvestigated for use/treatment in traumatic brain injuries.
IcatibantA bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE).
FasitibantFasitibant is under investigation in clinical trial NCT02205814 (Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee).
Drugs & Drug Targets
DrugTargetType
AnatibantB2 bradykinin receptortarget
IcatibantB2 bradykinin receptortarget
IcatibantAminopeptidase Ntarget